Key result
Propofol, etomidate, and thiopental show no difference in cardiovascular safety or efficacy during electroconvulsive therapy.
Why the study?
Do propofol, etomidate, and thiopental differ in their effects on cardiovascular parameters, seizure variables, and cognitive functions in male patients undergoing electroconvulsive therapy?
Cohort
No
Do propofol, etomidate, and thiopental differ in their effects on cardiovascular parameters, seizure variables, and cognitive functions in male patients undergoing electroconvulsive therapy?
Answers are grounded in this paper and cite their sources.
Propofol, etomidate, and thiopental demonstrate similar safety and efficacy profiles when used for anesthesia during electroconvulsive therapy.
OBJECTIVES: This study aimed to compare the effects of propofol, thiopental, and etomidate, which are routinely used in anesthesia for electroconvulsive therapy (ECT), on the cardiovascular system, seizure variables, recovery, cognitive functions, and response to treatment. METHODS: Male patients hospitalized at the Seventh Psychiatry Clinics of the Bakırköy Teaching Hospital for Psychiatry, Neurology, and Neurosurgery who were treated with ECT were investigated prospectively. The effects on cardiovascular system parameters (heart rate, blood pressure, and blood oxygenation), seizure variables (duration and intensity of seizure), and recovery variables were recorded at every session, on prespecified time points, and the findings of the first session were used in this evaluation. In addition, clinical responses to treatment were evaluated with tests of cognitive functions before and after a course of ECT. Adverse effects were recorded. RESULTS: The sociodemographic characteristics of the 3 treatment groups were similar. There were no significant differences among the groups in terms of effects on cardiovascular system variables, seizure variables, and cognitive functions. The clinical response to ECT was good in all groups, without any significant differences. CONCLUSIONS: Propofol, etomidate, and thiopental are associated with similar safety and efficacy profiles.
No takes yet. Share an insight, caveat, or question.
Canbek et al. (2014) conducted a cohort in Electroconvulsive therapy (ECT). Propofol, etomidate, and thiopental vs. Compared against each other was evaluated on Effects on cardiovascular system parameters, seizure variables, recovery, cognitive functions, and response to treatment. Propofol, etomidate, and thiopental demonstrated similar safety and efficacy profiles, with no significant differences in cardiovascular, seizure, or cognitive variables during electroconvulsive therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: